Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo

Karandeep Singh Podcasts

show episodes
 
Artwork

1
The KD Talks

Karandeep Singh

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Daily+
 
Welcome to THE KD TALKS hosted by Karandeep Singh! 🎧 Join me for captivating case studies and insightful content, in Punjabi. Follow for regular episodes and let's dive into fascinating topics together! 🚀
  continue reading
 
NEJM AI Grand Rounds, hosted by Arjun (Raj) Manrai, Ph.D. and Andrew Beam, Ph.D., features informal conversations with a variety of unique experts exploring the deep issues at the intersection of artificial intelligence, machine learning, and medicine. You’ll learn how AI will change clinical practice and healthcare, how it will impact the patient experience, and about the people who are pushing for innovation. Whether you are an AI researcher or a practicing clinician, these conversations w ...
  continue reading
 
Artwork

1
Go Live

ACIF / Chase Parsons

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
'Go Live' is a podcast brought you by the AMIA Clinical Informatics Fellows (ACIF) which discusses the intersection of Medicine and Technology, while bringing you entertaining interviews from experts in the field.
  continue reading
 
Artwork

1
The AI Health Podcast

Pranav Rajpurkar, Adriel Saporta, Oishi Banerjee, Marc Robbins

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
Explore the ways in which AI will transform healthcare, biotech, and medicine through conversations with entrepreneurs, investors and scientists. Hosted by Pranav Rajpurkar and Adriel Saporta. Produced by Oishi Banerjee and Marc Robbins.
  continue reading
 
Loading …
show series
 
Dr. Karandeep Singh brings two worlds together: programming and medicine. In this conversation, he explains how early experiments with code led him to biomedical informatics, why gaps between paper performance and clinical reality must be confronted, and how governance committees weigh ethics and safety. Now serving as Chief Health AI Officer at UC…
  continue reading
 
In this episode, Michelle and guests take a deep dive into what’s really happening inside the FDA in 2025. From pre-submission strategies to the blurred line between wellness and medical devices, this discussion uncovers the latest regulatory trends shaping medtech. What you’ll learn in this episode: How to structure effective FDA pre-submissions (…
  continue reading
 
In the Season 1 finale, Michelle and Ti challenge the traditional view of regulatory affairs as the “business prevention department.” Instead, they reframe regulators as strategic partners and proactive innovators who can drive compliance and competitive advantage. From shocking stories of last-minute compliance scrambles to major recalls that resh…
  continue reading
 
In this episode of Device and Conquer, we unpack the differences between the FDA’s inspection style and the EU’s notified body-driven approach. From classification rules and audit methodologies (QSR, ISO 13485, MDSAP) to unannounced FDA inspections versus Europe’s annual surveillance audits, we dig into what medical device companies really need to …
  continue reading
 
Who really is the FDA and how do they regulate medical devices? In this episode of Device and Conquer, we break down the U.S. Food and Drug Administration’s role—from product classification and product codes to substantial equivalence, 510(k)s, de novos, and PMAs. Learn how the FDA oversees everything from tongue depressors to pacemakers and why re…
  continue reading
 
In this episode of the NEW Device and Conquer podcast, Michelle and co-host Ti dive deep into the European Union’s Medical Device Regulation (MDR) — and explain why it’s much more than just red tape. The conversation begins with a fun recap of their “Real or Ridiculous” game, where they fact-check quirky device ideas like smart spoons for Parkinson…
  continue reading
 
What exactly is a medical device — and why does it matter if it’s regulated? In this premiere episode of Device and Conquer, hosts Michelle Lott and Ti Benson unpack the surprisingly broad world of medical devices, from smart thermometers and glucose meters to fertility tech and connected implants. You’ll hear: The difference between drugs and devi…
  continue reading
 
Dr. Jeremy Friese knows medicine from both sides. A practicing radiologist and technology executive, he’s seen firsthand how administrative burden undermines care. In this episode of NEJM AI Grand Rounds, he walks through the origins of prior authorization, explains why he believes artificial intelligence can close the gap between patients and paye…
  continue reading
 
Dr. Andy Beam has trained models, mentored scientists, and used data to quantify the value of treatments. In this episode of NEJM AI Grand Rounds, Raj Manrai turns the table on his co-host, reflecting on how Andy’s childhood misdiagnosis, and the failure of human recall, revealed the diagnostic promise of machine learning. As a Harvard professor, h…
  continue reading
 
In this episode Michelle and Adam Foresman from Ryden Solutions do a deep dive into right-sizing quality systems, lean regulatory practices, and the evolving landscape of AI-driven compliance tools in medtech. They reflect on personal pain points that sparked their ventures, swap audit war stories, and share insights into regulatory shifts like QMS…
  continue reading
 
In this episode of NEJM AI Grand Rounds, guests Drs. Alan Karthikesalingam and Anil Palepu of Google walk co-hosts Raj Manrai and Andy Beam through the making and evaluation of AMIE, an AI system designed to conduct clinical conversations with patients. Alan and Anil explain how AMIE was trained using synthetic doctor-patient interactions generated…
  continue reading
 
The FDA Breakthrough Device Program offers a expedited path to market for medical devices that offer more effective treatment or diagnosis for life-threatening or irreversibly debilitating conditions. It allows for prioritized review and enhanced communication with the FDA to help bring innovative devices to market more quickly, but it's not for ev…
  continue reading
 
Dr. Shiv Rao, cardiologist and CEO of Abridge, joins hosts Raj Manrai and Andy Beam on NEJM AI Grand Rounds for an inspiring conversation at the intersection of medicine, technology, and meaning. Shiv shares the origin story of Abridge, reflecting on how a deeply human encounter in clinic sparked the idea for a company now transforming clinical doc…
  continue reading
 
Dr. Faisal Mahmood, Associate Professor of Pathology at Brigham and Women’s Hospital and Harvard Medical School, joins hosts Raj Manrai and Andy Beam on NEJM AI Grand Rounds to explore the frontier of computational pathology. From pioneering foundational models for whole slide imaging to commercializing a multimodal generative AI copilot for pathol…
  continue reading
 
Morgan Cheatham joins hosts Raj Manrai and Andy Beam on NEJM AI Grand Rounds to discuss the evolving landscape of artificial intelligence in health care, from its role in automating clinical documentation to its transformative potential in genomic medicine. A venture capitalist and future physician, Morgan shares how his background in computational…
  continue reading
 
Did you know that 60% of startups cannot survive beyond five years, and 75% will ultimately fail?These failures frequently stem from late regulatory involvement, underestimation of remaining development work, and the compounding effect of early oversights. To mitigate these risks, a structured approach is essential, emphasizing early and continuous…
  continue reading
 
Dr. Emily Alsentzer joins hosts Raj Manrai and Andy Beam on NEJM AI Grand Rounds to discuss the evolution of natural language processing (NLP) in medicine. A Stanford faculty member and expert in clinical AI, Emily shares her journey from pre-med to biomedical AI, the role of language models in medical decision-making, and the ethical consideration…
  continue reading
 
Podcast of a July 2024 webinar event presented by Etienne Nichols and Greenlight Guru and featuring Karandeep Singh BadwalThe MDR is a comprehensive regulation that aims to improve patient safety and quality in the European Union, replacing the Medical Device Directive (MDD) and introducing more stringent requirements for manufacturers.LinkedIn: ht…
  continue reading
 
In this return appearance on NEJM AI Grand Rounds, Dr. Zak Kohane joins hosts Raj Manrai and Andy Beam to discuss the evolving landscape of AI in medicine. As the first repeat guest on the show, Dr. Kohane shares insights on health care system challenges, the Human Values Project, and his perspectives on the most significant AI developments of 2024…
  continue reading
 
In this episode of NEJM AI Grand Rounds, hosts Raj Manrai and Andy Beam interview Larry Summers about artificial intelligence’s transformative potential and its implications for society. The conversation explores Summers’ perspective on AI as potentially the most significant technology ever invented, his role on OpenAI’s board following the Novembe…
  continue reading
 
Everything you need to know about biocompatibility - in one podcast.From a webinar hosted by MedTech Leading Voice and featuring Michelle and Marina Daineko from Intrinsic Medical Group.LinkedIn: https://www.linkedin.com/in/michellelottraqaWebsite: https://leanraqa.com/YouTube: https://www.youtube.com/@leanRAQAInstagram: https://www.instagram.com/l…
  continue reading
 
In this episode of NEJM AI Grand Rounds, hosts Raj Manrai and Andy Beam interview Courtney Hofmann, a mother whose use of ChatGPT led to her son’s diagnosis of tethered cord syndrome after seeing 17 doctors over three years, and Dr. Holly Gilmer, the pediatric neurosurgeon who confirmed and treated the condition. The conversation explores how AI he…
  continue reading
 
In this episode of NEJM AI Grand Rounds, hosts Raj Manrai and Andy Beam interview Dr. David Ouyang, a cardiologist and AI researcher at Cedars-Sinai Medical Center. The conversation explores Ouyang’s journey from medical training to AI research and entrepreneurship, his groundbreaking work in applying AI to cardiology imaging, and the challenges of…
  continue reading
 
Which market is best for your product - the EU or the US?The answer is not always straightforward, but Ronald Boumans, Nika Mendelev and I did our level best to answer your questions in this Master Class presentation.Michelle leads off with a review of FDA strategies and pathways.15:34 - Ronald dives into the particulars of MDR and dealing with not…
  continue reading
 
Biocompatibility testing is hot right now, in part because of the sharp increase in the number of FDA submissions containing fraudulent data. Some unethical third-party testing labs are sending their clients data mined from old 510(k) submissions - and passing it off as fresh data.So what's a medical device manufacturer to do? That was the topic of…
  continue reading
 
In this episode of NEJM AI Grand Rounds, hosts Raj Manrai and Andy Beam interview Dr. Noa Dagan and Dr. Ran Balicer from the Clalit Research Institute in Israel. The conversation explores Clalit’s groundbreaking work in implementing predictive models at the point of care, their contributions to COVID-19 research, and the potential of AI in revoluti…
  continue reading
 
In this episode of NEJM AI Grand Rounds, hosts Raj Manrai and Andy Beam interview Dr. Vijay Pande, a general partner at Andreessen Horowitz (A16Z) where he leads investments in health care and life sciences. The conversation explores Pande’s journey from academia to venture capital, his views on the future of AI in health care and biomedicine, and …
  continue reading
 
In this episode of NEJM AI Grand Rounds, hosts Raj Manrai and Andy Beam interview Dr. Rohaid Ali and Dr. Fatima Mirza, a married couple and chief residents at Brown University. The conversation explores their innovative work applying AI to health care, focusing on two major projects: Using ChatGPT to simplify surgical consent forms, making them mor…
  continue reading
 
In this episode of the AI Grand Rounds podcast, Dr. Adam Rodman shares his unique journey from a historian to a physician deeply interested in the intersection of medicine and artificial intelligence. He highlights his unconventional path, driven by an obsession with epistemology and nosology, and his early exposure to AI through historical referen…
  continue reading
 
In this episode of the NEJM AI Grand Rounds podcast, Dr. Nigam Shah, a distinguished Professor of Medicine at Stanford University and inaugural Chief Data Scientist for Stanford Health Care, shares his journey from training as a doctor in India to becoming a leading figure in biomedical informatics in the United States. He discusses the transformat…
  continue reading
 
The good folks at Vistatec invited me to participate in their Life Science In-Focus podcast last month, where host Karen Tkaczyk and I chatted about the intricacies of regulatory affairs within the life sciences.We also discussed just how I ended up in the field, and the many challenges companies face when choosing regulatory pathways in the United…
  continue reading
 
This is not last year's eSTAR - a LOT has changed, and there are things you need to know before you try to submit your 510k. In this episode, we'll guide you through the intricacies of the latest eSTAR 5.0 platform, crucial for those of you planning a 510k or PMA submission.We'll review the eSTAR 5.0 platform and what you need to know to use it eff…
  continue reading
 
In this episode of the AI Grand Rounds podcast, Dr. Daphne Koller charts her professional trajectory, tracing her early fascination with computers to her influential role in AI and health care. Initially intrigued by the capacity of computers for decision-making based on theoretical principles, Koller witnessed her niche area — once considered peri…
  continue reading
 
In this episode of the AI Grand Rounds podcast, Dr. Eric Horvitz describes his career evolution from an interest in neurobiology to significant contributions in AI, particularly in understanding complex systems and applying AI in medicine. He discusses the shift from studying neurobiology to embracing AI and computational methods as tools for unrav…
  continue reading
 
Why would you use a 3rd party reviewer for your submission? How does a 3rd party reviewer function? How is it different from working with the FDA?I sat down with my good friend Shawnnah Monterrey from Beanstock Ventures to answer all your pressing questions about using 3rd party reviewers.LinkedIn: https://www.linkedin.com/in/michellelottraqaWebsit…
  continue reading
 
In this episode of the AI Grand Rounds podcast, Dr. James Zou shares his personal journey to discovering machine learning during his graduate studies at Harvard. Fascinated by the potential of AI and its application to genomics and medicine, Dr. Zou embarked on a journey that took him from journalism to the forefront of AI research. He has been ins…
  continue reading
 
When is it better for a medtech startup to hire a fractional quality professional, and when is it time to hire full-time? This is not necessarily an easy question to answer, and there can be a lot of factors impacting the decision. In this joint podcast with Mitch Robbins, we discuss the challenges and opportunities of today's topsy-turvy QA hiring…
  continue reading
 
In this episode of the AI Grand Rounds podcast, Dr. Roxana Daneshjou shares her journey from a childhood influenced by early exposure to science to her current role as an assistant professor at Stanford. Her path includes a critical shift during medical school, where her interest in computational methods and human genomics led her to pursue both an…
  continue reading
 
In this episode, Dr. Zak Kohane shares his journey into AI and medicine, reflecting on early influences from science fiction authors and programming experiences in his youth. He discusses his academic path, moving from programming and machine instruction to medical school, driven partly by practical advice and personal ambition. Kohane highlights h…
  continue reading
 
We're back with the second part of the Success Exposed- Asia's Richest Businessman. Get ready for more excitement in our podcast series! This time, we'll uncover the master plan of JIO & even more about how they became a Rich Businessman. The podcast is in Punjabi. Join us for a cool and easy chat about the challenges they faced and the secrets beh…
  continue reading
 
In this episode, Dr. Judy Wawira Gichoya, Associate Professor in the Department of Radiology and Imaging Sciences at Emory University School of Medicine, details her journey from Kenya to the United States, from interventional radiology to artificial intelligence. Transcript.By NEJM Group
  continue reading
 
As medical devices become more connected, concerns about security increase, leaving manufacturers - and regulatory staff - uncertain as to the best path forward. Listen in as Michelle and guest Randy Horton discuss industry needs and what the FDA plans to do to ensure the safety of connected and AI-driven devices.LinkedIn: https://www.linkedin.com/…
  continue reading
 
In this episode, vanguard geneticist Dr. George Church recounts his storied career from his early fascination with computers and science to his pioneering work in genomics and synthetic biology. Dr. Church developed innovative DNA sequencing methods that enabled the first sequencing of the human genome. He was also instrumental in developing CRISPR…
  continue reading
 
In this episode, we’re joined by business magnate and investor Mark Cuban. Cuban describes his journey from humble beginnings as a self-taught programmer to becoming a successful serial entrepreneur and owner of an NBA team. Cuban shares the founding story of his pharmacy benefits company, Cost Plus Drugs, and his vision for reimagining the reimbur…
  continue reading
 
In this episode, pioneering informatician Dr. Atul Butte guides listeners through his storied career, from his early days as a pediatric endocrinologist and informatician in Boston to his trailblazing work on the West Coast. Dr. Butte describes his trailblazing efforts to both harness large-scale public biomedical data and share patient data across…
  continue reading
 
Many manufacturers see quality as a necessary evil, a box to be checked just to placate the FDA on the way to market launch. But it can be SO much more.In this episode, Ti Benson and I discuss how quality can actually be a business benefit and not simply something to be endured.LinkedIn: https://www.linkedin.com/in/michellelottraqaWebsite: https://…
  continue reading
 
You may think document control is boring, but wait until you hear these stories:Red-lined post-it notes. Uncontrolled copies passed around during inspections. Master files stored on a desktop instead of in the eQMS system. Secret file cabinets in locked closets full of uncontrolled, red-lined specifications documents.Oh, the joy of document control…
  continue reading
 
The best leaders know that quality is much more than a box to be checked, or a necessary evil to be endured along the road to FDA (or MDR) approval.This is the third in a series of conversations talking about quality and how it can actually benefit a company, and even give you an advantage over your competition.LinkedIn: https://www.linkedin.com/in…
  continue reading
 
In this thought-provoking episode, Dr. Ziad Obermeyer delves into the complex issues of bias, safety, and generalizability of medical AI. Dr. Obermeyer emphasizes the importance of machine learning researchers’ task formulation, an often-overlooked yet significant determinant of bias in AI algorithms. Highlighting the dual impact of machine learnin…
  continue reading
 
Loading …
Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play